Hexagon's Capital Markets Day 2019 will be Broadcasted Live
NACKA STRAND, Sweden, Dec. 9, 2019 /PRNewswire/ -- Hexagon will host its Capital Markets Day on Wednesday 11th of December in Cobham, UK. Ola Rollén, President and CEO at Hexagon, will together with members of Group Management hold presentations on current market trends, growth opportunities and key strategic focus areas.
Those unable to attend the Capital Markets Day in person can follow the online broadcast live as well as on demand at hexagon.com. Please find the link to the webcast here.
The webcast will be active at 10.00 GMT (11.00 CET) on Wednesday, 11th of December.
Following the event, the presentation material will also be available on the company's website.
For further information, please contact: Maria Luthström, Head of Investor Relations, Hexagon AB, +46-8-601-26-27, [email protected] Kristin Christensen, Chief Marketing Officer, Hexagon AB, +1-404-554-0972, [email protected]
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
